Literature DB >> 22565310

Nuclear protein 1 promotes pancreatic cancer development and protects cells from stress by inhibiting apoptosis.

Tewfik Hamidi1, Hana Algül, Carla Eliana Cano, Maria José Sandi, Maria Inés Molejon, Marc Riemann, Ezequiel Luis Calvo, Gwen Lomberk, Jean-Charles Dagorn, Falk Weih, Raul Urrutia, Roland Michael Schmid, Juan Lucio Iovanna.   

Abstract

Pancreatic ductal adenocarcinoma (PDAC) has the lowest survival rate of all cancers and shows remarkable resistance to cell stress. Nuclear protein 1 (Nupr1), which mediates stress response in the pancreas, is frequently upregulated in pancreatic cancer. Here, we report that Nupr1 plays an essential role in pancreatic tumorigenesis. In a mouse model of pancreatic cancer with constitutively expressed oncogenic Kras(G12D), we found that loss of Nupr1 protected from the development of pancreatic intraepithelial neoplasias (PanINs). Further, in cultured pancreatic cells, nutrient deprivation activated Nupr1 expression, which we found to be required for cell survival. We found that Nupr1 protected cells from stress-induced death by inhibiting apoptosis through a pathway dependent on transcription factor RelB and immediate early response 3 (IER3). NUPR1, RELB, and IER3 proteins were coexpressed in mouse PanINs from Kras(G12D)-expressing pancreas. Moreover, pancreas-specific deletion of Relb in a Kras(G12D) background resulted in delayed in PanIN development associated with a lack of IER3 expression. Thus, efficient PanIN formation was dependent on the expression of Nupr1 and Relb, with likely involvement of IER3. Finally, in patients with PDAC, expression of NUPR1, RELB, and IER3 was significantly correlated with a poor prognosis. Cumulatively, these results reveal a NUPR1/RELB/IER3 stress-related pathway that is required for oncogenic Kras(G12D)-dependent transformation of the pancreas.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22565310      PMCID: PMC3366404          DOI: 10.1172/JCI60144

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  58 in total

1.  Expression of the stress-induced p8 mRNA is transiently activated after culture medium change.

Authors:  A Garcia-Montero; S Vasseur; G V Mallo; P Soubeyran; J C Dagorn; J L Iovanna
Journal:  Eur J Cell Biol       Date:  2001-11       Impact factor: 4.492

2.  Accomplishments in 2008 in the management of localized pancreatic cancer.

Authors:  Eileen M O'Reilly; Manfred P Lutz; Peter Neuhaus
Journal:  Gastrointest Cancer Res       Date:  2009-09

3.  Expression of p8 in human pancreatic cancer.

Authors:  S B Su; Y Motoo; J L Iovanna; M J Xie; H Mouri; K Ohtsubo; Y Yamaguchi; H Watanabe; T Okai; F Matsubara; N Sawabu
Journal:  Clin Cancer Res       Date:  2001-02       Impact factor: 12.531

4.  Transforming growth factor beta-1 enhances Smad transcriptional activity through activation of p8 gene expression.

Authors:  A C García-Montero; S Vasseur; L E Giono; E Canepa; S Moreno; J C Dagorn; J L Iovanna
Journal:  Biochem J       Date:  2001-07-01       Impact factor: 3.857

5.  Tumor necrosis factor alpha induces the expression of the nuclear protein p8 via a novel NF kappaB binding site within the promoter.

Authors:  K Kallwellis; R Grempler; S Günther; G Päth; R Walther
Journal:  Horm Metab Res       Date:  2006-09       Impact factor: 2.936

6.  p73beta-Mediated apoptosis requires p57kip2 induction and IEX-1 inhibition.

Authors:  Susana Gonzalez; Manuel M Perez-Perez; Eva Hernando; Manuel Serrano; Carlos Cordon-Cardo
Journal:  Cancer Res       Date:  2005-03-15       Impact factor: 12.701

7.  P8 expression is induced in acinar cells during chronic pancreatitis.

Authors:  Y Motoo; J L Iovanna; G V Mallo; S B Su; M J Xie; N Sawabu
Journal:  Dig Dis Sci       Date:  2001-08       Impact factor: 3.199

8.  Tumor-suppressor function of SPARC-like protein 1/Hevin in pancreatic cancer.

Authors:  Irene Esposito; Hany Kayed; Shereen Keleg; Thomas Giese; E Helene Sage; Peter Schirmacher; Helmut Friess; Jörg Kleeff
Journal:  Neoplasia       Date:  2007-01       Impact factor: 5.715

9.  Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma.

Authors:  Andrew J Aguirre; Nabeel Bardeesy; Manisha Sinha; Lyle Lopez; David A Tuveson; James Horner; Mark S Redston; Ronald A DePinho
Journal:  Genes Dev       Date:  2003-12-17       Impact factor: 11.361

Review 10.  The sunset of somatic genetics and the dawn of epigenetics: a new frontier in pancreatic cancer research.

Authors:  Gwen Lomberk; Angela J Mathison; Adrienne Grzenda; Raul Urrutia
Journal:  Curr Opin Gastroenterol       Date:  2008-09       Impact factor: 3.287

View more
  65 in total

1.  Identification of a mitochondrial defect gene signature reveals NUPR1 as a key regulator of liver cancer progression.

Authors:  Young-Kyoung Lee; Byul A Jee; So Mee Kwon; Young-Sil Yoon; Wei Guang Xu; Hee-Jung Wang; Xin Wei Wang; Snorri S Thorgeirsson; Jae-Seon Lee; Hyun Goo Woo; Gyesoon Yoon
Journal:  Hepatology       Date:  2015-08-07       Impact factor: 17.425

2.  Ligand-based design identifies a potent NUPR1 inhibitor exerting anticancer activity via necroptosis.

Authors:  Patricia Santofimia-Castaño; Yi Xia; Wenjun Lan; Zhengwei Zhou; Can Huang; Ling Peng; Philippe Soubeyran; Adrián Velázquez-Campoy; Olga Abián; Bruno Rizzuti; José L Neira; Juan Iovanna
Journal:  J Clin Invest       Date:  2019-03-28       Impact factor: 14.808

3.  Interaction of the Androgen Receptor, ETV1, and PTEN Pathways in Mouse Prostate Varies with Pathological Stage and Predicts Cancer Progression.

Authors:  Jake Higgins; Michele Brogley; Nallasivam Palanisamy; Rohit Mehra; Michael M Ittmann; Jun Z Li; Scott A Tomlins; Diane M Robins
Journal:  Horm Cancer       Date:  2015-01-29       Impact factor: 3.869

4.  NUPR1 maintains autolysosomal efflux by activating SNAP25 transcription in cancer cells.

Authors:  Yanchao Mu; Xiaojie Yan; Ding Li; Dan Zhao; Lingling Wang; Xiaoyang Wang; Dan Gao; Jie Yang; Hua Zhang; Yanzhe Li; Yanan Sun; Yiliang Wei; Zhenfa Zhang; Xinzhong Chang; Zhi Yao; Shanshan Tian; Kai Zhang; Lance S Terada; Zhenyi Ma; Zhe Liu
Journal:  Autophagy       Date:  2017-12-31       Impact factor: 16.016

5.  IER3 supports KRASG12D-dependent pancreatic cancer development by sustaining ERK1/2 phosphorylation.

Authors:  Maria Noé Garcia; Daniel Grasso; Maria Belen Lopez-Millan; Tewfik Hamidi; Celine Loncle; Richard Tomasini; Gwen Lomberk; Françoise Porteu; Raul Urrutia; Juan L Iovanna
Journal:  J Clin Invest       Date:  2014-09-24       Impact factor: 14.808

Review 6.  Role of abnormal lipid metabolism in development, progression, diagnosis and therapy of pancreatic cancer.

Authors:  Julian Swierczynski; Areta Hebanowska; Tomasz Sledzinski
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

7.  Intrinsically disordered chromatin protein NUPR1 binds to the C-terminal region of Polycomb RING1B.

Authors:  Patricia Santofimia-Castaño; Bruno Rizzuti; Ángel L Pey; Philippe Soubeyran; Miguel Vidal; Raúl Urrutia; Juan L Iovanna; José L Neira
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-18       Impact factor: 11.205

8.  RNA-Seq Analysis of Islets to Characterise the Dedifferentiation in Type 2 Diabetes Model Mice db/db.

Authors:  Abraham Neelankal John; Ramesh Ram; Fang-Xu Jiang
Journal:  Endocr Pathol       Date:  2018-09       Impact factor: 3.943

Review 9.  Immediate early response gene X-1, a potential prognostic biomarker in cancers.

Authors:  Mei X Wu; Irina V Ustyugova; Liping Han; Oleg E Akilov
Journal:  Expert Opin Ther Targets       Date:  2013-02-04       Impact factor: 6.902

10.  The Receptor for Advanced Glycation Endproducts Drives T Cell Survival and Inflammation in Type 1 Diabetes Mellitus.

Authors:  Sean P Durning; Paula Preston-Hurlburt; Paul R Clark; Ding Xu; Kevan C Herold
Journal:  J Immunol       Date:  2016-09-21       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.